Biostatistisk analyse af denne undersøgelse kan muligvis være velegnet til at vurdere den intra- individuelle variation og betydningen af de forskellige udløsningssystemers biofarmaceutiske funktion (reservoir kontra matrix).
The biostatistical evaluation of the existing single dose study with replicate design (but showing non- bioequivalence) could be considered suitable to evaluate intra-individual variability and to determine the influence of the biopharmaceutical performance, in relation to the different release mechanisms (reservoir versus matrix).